Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Trocade

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundPneumococcal meningitis is associated with high mortality and morbidity rates. Up to 50% of survivors show neurologic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
ABSTRACT Pneumococcal meningitis (PM) results in high mortality rates and long-lasting neurological deficits. Hippocampal… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2006
2006
The structural features contributing to the different pharmacokinetic properties of the TACE/MMP inhibitors TNF484 and Trocade… Expand
Highly Cited
2005
Highly Cited
2005
1 FR255031 (2‐[(7S)‐7‐[5‐(4‐ethylphenyl)‐2‐thienyl]‐1,1‐dioxido‐4‐(2‐pyridinylcarbonyl)hexahydro‐1,4‐thiazepin‐7‐yl]‐N… Expand
Highly Cited
2003
Highly Cited
2003
The application of a new hybrid RF/DC quadrupole-linear ion trap mass spectrometer to support drug metabolism and pharmacokinetic… Expand
Highly Cited
2002
Highly Cited
2002
Background: Anti-tumour necrosis factor α (TNF-α) antibodies are effective in Crohn's disease and perhaps ulcerative colitis but… Expand
Highly Cited
2002
Highly Cited
2002
BACKGROUND Anti-tumour necrosis factor alpha (TNF-alpha) antibodies are effective in Crohn's disease and perhaps ulcerative… Expand
2002
2002
A new series of succinate-based dual inhibitors against matrix metalloproteinases (MMPs) and tumor necrosis factor alpha… Expand
2001
2001
OBJECTIVES The purpose of this study was to assess the tolerability and multiple-dose pharmacokinetics of Trocade in rheumatoid… Expand
Review
2001
Review
2001
  • D. Close
  • Annals of the rheumatic diseases
  • 2001
  • Corpus ID: 17835603
The rheumatic diseases continue to represent a significant healthcare burden in the 21st century. However, despite the best… Expand